Variable | Adjusted odds ratio (95 % CI) | P-value |
---|---|---|
Risk 1: age ˂60 years, normal kidney function (MDRD ˃90), normal liver function (MELD ˂8) | ||
ICU mortality | ||
CPOE protocol | 0.82 (0.12–5.63) | 0.84 |
Revised CPOE protocol | 0.45 (0.07–2.99) | 0.41 |
APACHE II | 1.22 (1.07–1.38) | 0.002 |
Hospital mortality | ||
CPOE protocol | 0.67 (0.13–3.48) | 0.63 |
Revised CPOE protocol | 0.21 (0.04–1.16) | 0.07 |
APACHE II | 1.13 (1.00–1.28) | 0.0492 |
GCS | 0.87 (0.73–1.03) | 0.11 |
Risk 2: age = 60–70 years, moderate kidney function impairment (MDRD = 30–90), moderate liver function impairment (MELD = 8–14) | ||
ICU mortality | ||
CPOE protocol | 0.54 (0.06–4.82) | 0.58 |
Revised CPOE protocol | 1.43 (0.15–13.88) | 0.76 |
GCS | 1.47 (0.99–2.18) | 0.06 |
Hospital mortality | ||
CPOE protocol | 0.59 (0.09–4.01) | 0.59 |
Revised CPOE protocol | 1.15 (0.198–6.74) | 0.87 |
Risk 3: age ˃70 years, severe kidney function impairment (MDRD ˂30), severe liver function impairment (MELD ˃14) | ||
ICU mortality | ||
CPOE protocol | 2.64 (1.03–6.56) | 0.04 |
Revised CPOE protocol | 0.68 (0.24–1.88) | 0.45 |
Chronic cardiovascular disease | 2.07 (0.81–5.30) | 0.13 |
Chronic liver disease | 5.87 (1.99–17.27) | 0.001 |
APACHE II | 1.11 (1.05–1.18) | 0.0002 |
Hospital mortality | ||
CPOE protocol | 1.43 (0.59–3.46) | 0.43 |
Revised CPOE protocol | 1.11 (0.44–2.79) | 0.82 |
Chronic liver disease | 3.25 (1.07–9.84) | 0.04 |
APACHE II | 1.12 (1.06–1.19) | <0.0001 |